Pyrojas

1 known investors

Pyrojas develops whole-cell cancer vaccines engineered from patients' own tumors to activate T cell responses against multiple antigens. The company focuses on precision immunotherapy for cancer treatment.

AI & Machine LearningBiotechMedical Devices